| 9th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 8th Jun 2023 12:31 pm |
RNS |
Form 8.3 - Shield Therapeutics PLC (amendment) |
| 8th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 8th Jun 2023 7:00 am |
RNS |
Acceptance Level Update |
| 7th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 6th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 6th Jun 2023 10:10 am |
RNS |
Grant of share options to the CEO |
| 5th Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 2nd Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 1st Jun 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 1st Jun 2023 11:00 am |
RNS |
Holding(s) in Company |
| 1st Jun 2023 10:55 am |
RNS |
Holding(s) in Company |
| 31st May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 31st May 2023 7:00 am |
RNS |
Total Voting Rights |
| 30th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 26th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 25th May 2023 4:44 pm |
RNS |
Publication and posting of Offer Document |
| 25th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 24th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 23rd May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 22nd May 2023 1:25 pm |
RNS |
Form 8.3 - Shield Therapeutics PLC |
| 19th May 2023 4:17 pm |
RNS |
Form 8.3 - Shield Therapeutics Plc |
| 19th May 2023 2:29 pm |
RNS |
Form 8.3 – Shield Therapeutics plc |
| 19th May 2023 7:00 am |
RNS |
2022 Annual Report and 2023 AGM Notice |
| 18th May 2023 3:15 pm |
RNS |
Form 8 (OPD) - Shield Therapeutics plc |
| 18th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 17th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 17th May 2023 7:15 am |
EQS |
Hardman & Co Research on Shield Therapeutics (STX): Reassuring 1Q’23 Accrufer prescriptions |
| 16th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 12th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 11th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 10th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 9th May 2023 5:20 pm |
RNS |
Form 8 (OPD) - Shield Therapeutics plc |
| 9th May 2023 4:00 pm |
RNS |
Rule 2.9 Announcement and TVR Update |
| 9th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 9th May 2023 11:04 am |
GNW |
Form 8.3 - Shield Therapeutics plc |
| 5th May 2023 3:09 pm |
RNS |
Form 8 (DD) - Shield Therapeutics Plc |
| 5th May 2023 12:00 pm |
RNS |
Form 8.5 (EPT/RI) - Shield Therapeutics Plc |
| 5th May 2023 11:55 am |
RNS |
Form 8.3 - SHIELD THERAPEUTICS PLC |
| 4th May 2023 2:40 pm |
RNS |
AOP Loan Conversion and Mandatory Cash Offer |
